Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-20 of 32

Sort by

Sort Order Select

Journal Articles

Cardiovascular safety profile of CD20 × CD3 bispecific antibodies compared to immune-checkpoint inhibitors: A faers analysis, 2014–2025

Manzer Ali, Zayd Parekh, Rohan Mylavarapu, Saad Rashid, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Hanzala Jehangir, Rajesh Thirumaran, Aftab Ahmed, Mohammed AL-Jumayli, Kirti Arora, Kevin Bera, Bolivia Fernandes

Blood (2025) 146 (Supplement 1): 7657.

https://doi.org/10.1182/blood-2025-7657

Published: 2025

Journal Articles

Therapeutic trade-offs between ide-cel and cilta-cel in RRMM: A meta-analytic comparison of efficacy and adverse events

Mobina Golmohammadi, Shahzad Raza, Doris Hansen, Sandra Mazzoni, Louis Williams, Kirti Arora, Haleema Sadia Adil, Faiz Anwer, Majid Jaberi

Blood (2025) 146 (Supplement 1): 7606.

https://doi.org/10.1182/blood-2025-7606

Published: 2025

Journal Articles

Artificial intelligence system for delivering interactive and verifiable guideline-based clinical decision support in hematology

Jiasheng Wang, Kirti Arora, David Swoboda, Aziz Nazha

Blood (2025) 146 (Supplement 1): 2578.

https://doi.org/10.1182/blood-2025-2578

Published: 2025

Journal Articles

Front‑line ponatinib vs imatinib in newly diagnosed Philadelphia‑positive ALL: Systematic review and meta‑analysis of survival and deep molecular response

Kirti Arora, Preksha Singh, Prudence Lam, Abhi Shah

Blood (2025) 146 (Supplement 1): 6862.

https://doi.org/10.1182/blood-2025-6862

Published: 2025

Journal Articles

Age at diagnosis shapes stage and survival in diffuse large B-cell lymphoma: A 22-year, population-based study of 94,598 SEER patients

Aftab Ahmed, Rajesh Thirumaran, Manzer Ali, Hanzala Jehangir, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Mohammed AL-Jumayli, Jaison Lawrence Alexander Santhi, Kevin Bera, Kirti Arora, Bolivia Fernandes, Muhammad Umer Javaid, Muhammad Arham

Blood (2025) 146 (Supplement 1): 3666.

https://doi.org/10.1182/blood-2025-3666

Published: 2025

Journal Articles

Thromboembolic and cardiovascular events after CAR-T cell therapy in multiple myeloma: A propensity-matched real-world analysis

Moath Albliwi, Firas Anaya, Rahaf Yaghi, Faris Naffa', Mohammed Aloqaily, Shrishti Sinha, Kirti Arora, Mustafa Tawaha, Ayham Hussein, Abdo Haddad, Hamed Daw, Wahid Aloweiwi, Moaath Mustafa Ali

Blood (2025) 146 (Supplement 1): 2249.

https://doi.org/10.1182/blood-2025-2249

Published: 2025

Journal Articles

Patients with multiple myeloma and CKD: Should we really hold off on bispecific therapy in this subgroup?

Kirti Arora, Rishi Chowdhary, Diana Basali, Christy Samaras, Akriti Jain, Deevyashali Parekh, Jason Valent, Jack Khouri, Louis Williams, Sandra Mazzoni, Abhay Singh, Faiz Anwer, Shahzad Raza

Blood (2025) 146 (Supplement 1): 2248.

https://doi.org/10.1182/blood-2025-2248

Published: 2025

Journal Articles

Real-world survival trends in smoldering versus symptomatic multiple myeloma: A SEER analysis, 2012–2020

Manzer Ali, Bolivia Fernandes, Rajesh Thirumaran, Kirti Arora, Hanzala Jehangir, Aftab Ahmed, Mohammed AL-Jumayli, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Kevin Bera, Jamal Abdul Nasir, Rameen Nadeem Nadeem

Blood (2025) 146 (Supplement 1): 8127.

https://doi.org/10.1182/blood-2025-8127

Published: 2025

Journal Articles

Increased risk of gastrointestinal complications in older adults with multiple myeloma: A propensity matched nationwide cohort study

Kirti Arora, Rishi Chowdhary, Aditi Arora, Moath Albliwi, Rachel Mcnulty, Preksha Singh, Juhi Chovatiya, Manzer Ali, Kashish Magnani, Shahzad Raza

Blood (2025) 146 (Supplement 1): 8126.

https://doi.org/10.1182/blood-2025-8126

Published: 2025

Journal Articles

Artificial intelligence enhanced prognostication in rare Acute Myeloid Leukemia subtypes with BCR::ABL1 and inv(3)/t(3;): A systematic review

Kirti Arora, Prachi Dawer, Adeel Khan

Blood (2025) 146 (Supplement 1): 7878.

https://doi.org/10.1182/blood-2025-7878

Published: 2025

Journal Articles

Early detection of emerging safety signals in GVHD prophylaxis agents using a 12-year faers “slope-watch” approach

Manzer Ali, Bolivia Fernandes, Rajesh Thirumaran, Hanzala Jehangir, Mohammed AL-Jumayli, Aftab Ahmed, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Kirti Arora, Kevin Bera, Jamal Abdul Nasir, Arbaz Hassan

Blood (2025) 146 (Supplement 1): 7767.

https://doi.org/10.1182/blood-2025-7767

Published: 2025

Journal Articles

Early versus late onset hematologic immune‐related adverse events following immune checkpoint inhibition: Temporal patterns, clinical profiles, and risk stratification in faers reports (2014–2025)

Aftab Ahmed, Manzer Ali, Rajesh Thirumaran, Hanzala Jehangir, Mohammed AL-Jumayli, Kirti Arora, Kevin Bera, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Bolivia Fernandes, Muhammad Umer Javaid, Muhammad Arham

Blood (2025) 146 (Supplement 1): 7659.

https://doi.org/10.1182/blood-2025-7659

Published: 2025

Journal Articles

Clone wars: Evidence of clonal stability in a longitudinal prospective cohort of cancer survivors with serial NGS analysis

Blood (2025) 146 (Supplement 1): 6712.

https://doi.org/10.1182/blood-2025-6712

Published: 2025

Journal Articles

Risk of venous and arterial thromboembolic events following CAR-T therapy in relapsed or refractory non-Hodgkin lymphoma: A propensity-matched multicenter analysis.

Faris Naffa, Moath Albliwi, Firas Anaya, Rahaf Yaghi, Kirti Arora, Shrishti Sinha, Mohammed Aloqaily, Mohammad Aljarbouah, Moaath Mustafa Ali

Blood (2025) 146 (Supplement 1): 3729.

https://doi.org/10.1182/blood-2025-3729

Published: 2025

Journal Articles

Changing patterns and comparative outcomes of “watch-and-wait” versus immediate therapy in CLL: A propensity-weighted SEER analysis, 2000–2020

Manzer Ali, Kashish Magnani, Saad Rashid, Daniel Rosas, Muhammad Awais Bin Abdul Malik, Rajesh Thirumaran, Kevin Bera, Hanzala Jehangir, Mohammed AL-Jumayli, Aftab Ahmed, Kirti Arora, Bolivia Fernandes, Jamal Abdul Nasir

Blood (2025) 146 (Supplement 1): 8069.

https://doi.org/10.1182/blood-2025-8069

Published: 2025

Journal Articles

Early post-marketing safety signals of CRISPR-edited exagamglogene autotemcel (Casgevy) versus lentiviral betibeglogene autotemcel (Zynteglo): A faers disproportionality study, 2014–2025

Aftab Ahmed, Rajesh Thirumaran, Manzer Ali, Hanzala Jehangir, Daniel Rosas, Jaison Lawrence Alexander Santhi, Muhammad Awais Bin Abdul Malik, Kevin Bera, Mohammed AL-Jumayli, Kirti Arora, Bolivia Fernandes, Muhammad Umer Javaid, Muhammad Arham

Blood (2025) 146 (Supplement 1): 7838.

https://doi.org/10.1182/blood-2025-7838

Published: 2025

Journal Articles

Prescribing patterns in MDS/MPN syndromes

Kirti Arora, Jahanvi Grover, Kelsey Pandrangi, Aditi Arora, Rishi Chowdhary, Manzer Ali, Akriti Jain, Sudipto Mukherjee, Aaron Gerds, Abhay Singh

Blood (2025) 146 (Supplement 1): 7375.

https://doi.org/10.1182/blood-2025-7375

Published: 2025

Journal Articles

Blood heavy-metal levels and risk of hematologic cancer in u.S. adults: Nhanes 2021–2023

Kirti Arora, Preksha Singh, Laurie Matt-Amaral

Blood (2025) 146 (Supplement 1): 6841.

https://doi.org/10.1182/blood-2025-6841

Published: 2025

Journal Articles

Underexplored mutations in plasma cell myeloma

Kirti Arora, Diana Basali, Yasar Shad, Akriti Jain, Christy Samaras, Haleema Sadia Adil, Jason Valent, Louis Williams, Jack Khouri, Sandra Mazzoni, Faiz Anwer, Abhay Singh, Shahzad Raza

Blood (2025) 146 (Supplement 1): 4025.

https://doi.org/10.1182/blood-2025-4025

Published: 2025

Journal Articles

Impact of age on outcomes of CAR-T cell therapy in multiple myeloma, DLBCL, and follicular lymphoma: A real-world multi-center propensity-matched analysis

Mohammed Aloqaily, Moath Albliwi, Rahaf Yaghi, Alexander Rabadi, Kirti Arora, Faris Naffa, Abdallah Al-Muhtaseb, Moaath Mustafa Ali

Blood (2025) 146 (Supplement 1): 2773.

https://doi.org/10.1182/blood-2025-2773

Published: 2025

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Cardiovascular safety profile of CD20 × CD3 bispecific antibodies compared to immune-checkpoint inhibitors: A faers analysis, 2014–2025

Therapeutic trade-offs between ide-cel and cilta-cel in RRMM: A meta-analytic comparison of efficacy and adverse events

Artificial intelligence system for delivering interactive and verifiable guideline-based clinical decision support in hematology

Front‑line ponatinib vs imatinib in newly diagnosed Philadelphia‑positive ALL: Systematic review and meta‑analysis of survival and deep molecular response

Age at diagnosis shapes stage and survival in diffuse large B-cell lymphoma: A 22-year, population-based study of 94,598 SEER patients

Thromboembolic and cardiovascular events after CAR-T cell therapy in multiple myeloma: A propensity-matched real-world analysis

Patients with multiple myeloma and CKD: Should we really hold off on bispecific therapy in this subgroup?

Real-world survival trends in smoldering versus symptomatic multiple myeloma: A SEER analysis, 2012–2020

Increased risk of gastrointestinal complications in older adults with multiple myeloma: A propensity matched nationwide cohort study

Artificial intelligence enhanced prognostication in rare Acute Myeloid Leukemia subtypes with BCR::ABL1 and inv(3)/t(3;): A systematic review

Early detection of emerging safety signals in GVHD prophylaxis agents using a 12-year faers “slope-watch” approach

Early versus late onset hematologic immune‐related adverse events following immune checkpoint inhibition: Temporal patterns, clinical profiles, and risk stratification in faers reports (2014–2025)

Clone wars: Evidence of clonal stability in a longitudinal prospective cohort of cancer survivors with serial NGS analysis

Risk of venous and arterial thromboembolic events following CAR-T therapy in relapsed or refractory non-Hodgkin lymphoma: A propensity-matched multicenter analysis.

Changing patterns and comparative outcomes of “watch-and-wait” versus immediate therapy in CLL: A propensity-weighted SEER analysis, 2000–2020

Early post-marketing safety signals of CRISPR-edited exagamglogene autotemcel (Casgevy) versus lentiviral betibeglogene autotemcel (Zynteglo): A faers disproportionality study, 2014–2025

Prescribing patterns in MDS/MPN syndromes

Blood heavy-metal levels and risk of hematologic cancer in u.S. adults: Nhanes 2021–2023

Underexplored mutations in plasma cell myeloma

Impact of age on outcomes of CAR-T cell therapy in multiple myeloma, DLBCL, and follicular lymphoma: A real-world multi-center propensity-matched analysis

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only